Write a one-page brief, confirm the active physically fits in a strip before you spend on branding, then pilot in the pack count you intend to sell. For a supplement, the regulatory work (facility registration, Supplement Facts panel, structure/function notification) runs alongside development, not after it.
Write the brief before you call anyone
One page. Who buys it, when they use it, the active and dose per serving, flavor direction, strips per serving and per box, launch month, and the cash you can tie up in the first run. Mark which items are fixed; a manufacturer can only give a useful feasibility answer against a brief that separates must-haves from preferences.
The dose line matters most. Reviews put quick-release films at roughly 2 to 8 cm2 and 20 to 70 um thick, with the active at about 5 to 30 percent of dry film weight (Palezi et al., 2023). Our standard strip is 22 x 32 mm, about 7 cm2, 50 to 150 um dry and 100 to 300 mg finished, with a single-active development target up to about 250 mg. Retail products span that range: Listerine PocketPaks carry flavor and a few actives in a pullulan base, while the Gas-X thin strip cited in the literature holds 62.5 mg of simethicone (Sevinc Ozakar and Ozakar, 2021).
Rule of thumb: under about 25 mg of a water-soluble active, a single strip is realistic and taste work is modest. Between 25 and 250 mg, expect bitterness masking, a thicker film and a slower dissolve. Above 250 mg per serving, plan a two-strip serving or pick a different format.
Do the regulatory paperwork in parallel
For a U.S. dietary supplement, four items sit on the brand owner, not the manufacturer, and none of them wait for the pilot.
Facility registration under 21 CFR 1.230 must exist before a facility manufactures, packs or holds food, and renews between October 1 and December 31 of every even-numbered year. If you hold your own inventory, ask whether your warehouse needs one.
The Supplement Facts panel follows 21 CFR 101.36: serving size in the unit sold ("1 strip"), body text no smaller than 8 point, dropping to 6 point on packages of 12 to 40 square inches and 4.5 point under 12. Those small-package allowances are what make a strip carton workable.
Any structure/function statement triggers 21 CFR 101.93: notify FDA within 30 days of first marketing, and print the disclaimer "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." in bold at least one-sixteenth of an inch high on each panel that carries the claim.
An ingredient not sold in the U.S. before October 15, 1994 needs a new dietary ingredient notification at least 75 days before shipping under 21 CFR 190.6. Put it on the calendar or choose an ingredient with a history of use.
Confirm feasibility, then develop against written criteria
Our program runs feasibility in 3 to 5 business days, formula development in 2 to 4 weeks, sample iteration in 1 to 3 weeks, the pilot in 2 to 4 weeks, and testing and release in about a week: 6 to 10 weeks to released pilot product once the brief is settled.
Every sample round needs pass/fail criteria written in advance. Dissolve time first: FDA's 2008 guidance for orally disintegrating tablets recommends about 30 seconds or less in vitro, film reviews report 5 to 30 seconds for light-load films (Irfan et al., 2016), and our development target is 30 to 60 seconds to leave room for heavier actives. Then taste at 0, 10 and 30 seconds, aftertaste at two minutes, residue on the tongue, how the strip peels from the sachet, and whether it survives a week in a pocket. Change one variable per round.
Pilot in the pack count you will sell
We run a 500-box pilot because it is large enough to exercise real packaging and release steps and small enough to correct. At 20 strips per box that is about 10,000 strips; at 30 it is 15,000.
Pick the count from the serving plan. Melatonin strips on Amazon are almost all 30-count (NuStrips 5 mg, EZStrip 5 mg with 10 mg L-theanine, Wellbeing Nutrition Melts 10 mg) because one strip a night makes 30 a monthly supply. Listerine sells PocketPaks 24 to a pack for an occasion product. Suboxone, a prescription film, ships 30 individually pouched films per carton.
Worked example. Marlow Coffee Co. wants a 50 mg caffeine strip, one strip per serving, occasional use, so 20-count. Pilot: 500 boxes x 20 = 10,000 sellable strips, plus about 300 held back for release testing and reserve samples, so the run is planned at roughly 10,300 strips. Active needed: 10,300 x 50 mg = 515 g caffeine. Timeline from signed brief to released product: 6 to 10 weeks. Allocation: 300 boxes to the web store, 100 to sampling and press, 70 to wholesale outreach, 30 held for review and replacements. Planning figures, not results.
Decide barrier and carton before artwork
Strips are hygroscopic, so the sachet is the shelf-life device. We spec a high-barrier PET/aluminum/PE laminate against a 24-month shelf-life target. The aluminum does the work: the European Aluminium Foil Association treats foil of at least 6 um as an absolute barrier for food contact, and the Sterilization Packaging Manufacturers Council notes that foil under 1 mil (25 um) is seldom pinhole-free but that a few 10 to 50 um pinholes barely change a laminate's water-vapor or oxygen transmission. Ask any supplier for the foil gauge and the laminate's WVTR.
Cartons run 10 to 60 count. Two fixed blocks constrain the smallest face: a UPC-A barcode is 37.29 x 25.9 mm at 100 percent and cannot go below 80 percent (29.8 x 20.7 mm) with quiet zones, and the Supplement Facts type size depends on total label area. Place both on the dieline before a designer touches it.
Testing, release, and the reorder file
21 CFR 111.70 requires written specifications for the finished product's identity, purity, strength, composition and contaminant limits; 21 CFR 111.75(c) requires testing against them on every batch or on a subset chosen by a statistical sampling plan; 21 CFR 111.83 requires reserve samples of at least twice the full-test quantity, held in the retail package for one year past the shelf-life date. That is why the 300-strip holdback in the example exists.
We apply standard release controls on every lot, send third-party testing through ILS Lab, and deliver a Lot Release Packet per lot. Whoever you use, ask for a blank batch record and check it against 21 CFR 111.260: lot number, equipment identity, component identifiers and weights, actual versus theoretical yield, in-process results, label reconciliation and the quality-control sign-off.
Then file the formula sheet, artwork, dielines, sachet and carton specs, specifications, batch record, certificates of analysis and retained units in one folder. The second run starts from that folder, not from memory.
Common questions
Published reviews put the active at roughly 5 to 30 percent of dry film weight, and most single strips in the literature carry 15 mg or less. Our development target reaches about 250 mg in a 100 to 300 mg finished strip. Above that, plan a two-strip serving.
The manufacturer registers its facility under 21 CFR 1.230. FDA's 2010 compliance guide still makes the own-label distributor responsible for knowing how the product was made and for the release decision, and any warehouse that holds finished product may need its own registration.
With a settled brief, our published phases add up to 6 to 10 weeks to released pilot product: feasibility 3 to 5 business days, formula development 2 to 4 weeks, sample iteration 1 to 3 weeks, pilot 2 to 4 weeks, testing and release about a week.
Primary sources
- Palezi S.C. et al., Oral disintegration films: applications and production methods, J Food Sci Technol 60(10):2539-2548 (2023)
- Sevinc Ozakar R., Ozakar E., Current overview of oral thin films, Turk J Pharm Sci 18(1):111-121 (2021)
- Irfan M. et al., Orally disintegrating films: a modern expansion in drug delivery system, Saudi Pharm J 24(5):537-546 (2016)
- FDA Guidance for Industry: Orally Disintegrating Tablets (Dec 2008)
- 21 CFR 1.230, Food facility registration and biennial renewal (Cornell LII)
- 21 CFR 101.36, Supplement Facts labeling (Cornell LII)
- 21 CFR 101.93, Structure/function claims and disclaimer (Cornell LII)
- 21 CFR 190.6, New dietary ingredient 75-day notification (Cornell LII)
- 21 CFR 111.70, Specifications (Cornell LII)
- 21 CFR 111.75, Testing of components and finished batches (Cornell LII)
- 21 CFR 111.83, Reserve samples (Cornell LII)
- 21 CFR 111.260, Batch production record contents (Cornell LII)
- FDA Small Entity Compliance Guide to 21 CFR part 111 (Dec 2010)
- Listerine Freshburst PocketPaks Breath Strips, 24-strip pack (H-E-B product listing)
- Listerine PocketPaks Cool Mint ingredient list (SkinSAFE)
- Suboxone sublingual film prescribing information, How Supplied (Drugs.com)
- NuStrips 5 mg melatonin strips, 30 count (Amazon listing)
- EZStrip 5 mg melatonin / 10 mg L-theanine strips, 30 count (Amazon listing)
- Wellbeing Nutrition Melts, 10 mg melatonin, 30 oral strips (Amazon listing)
- European Aluminium Foil Association, Reference Library (6 um foil as absolute barrier)
- Sterilization Packaging Manufacturers Council, Impact of pinholes in the foil layer of a lamination
- UPCGen, Barcode size and placement (GS1 UPC-A dimensions)
Formula feasibility, packaging, testing, claims, timing, and final quantities depend on the exact product. Use this guide to prepare better questions, then confirm the production plan for your project.